Jobs / United States / Keros Therapeutics INC

Keros Therapeutics INC

Director, Clinical Sciences

Lexington, MA (Hybrid) Posted today

Apply on employer site ↗ Tailor my CV first Source: Company careers site

Optional: we can tailor a CV and cover letter for this job from your real experience first (the first one is free).

Sponsorship verdict

Sponsorship possible

One solid signal, not two. Worth applying, and worth asking about sponsorship early.

  • Employer is on a government sponsor recordUSCIS Data Hub records 1 H-1B approvals for this employer in FY2023 — older 2023 data; no recent Department of Labor filings (Oct 2025 – Jun 2026) were found for it.
  • The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
  • No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area.
  • Confirmed live todayWhen a source last listed this job as open.
Details and sources
Employer is on a government sponsor record
USCIS Data Hub records 1 H-1B approvals for this employer in FY2023 — older 2023 data; no recent Department of Labor filings (Oct 2025 – Jun 2026) were found for it. Source: US Department of Labor visa filings (LCA) (US Department of Labor (OFLC), plus USCIS H-1B Employer Data Hub).
No salary bar for this route
H-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.

US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).

A verdict summarises public evidence. It is not legal advice and never a guarantee: the employer and the immigration authority decide. Sign in to factor in where you can already work.

About the role

At Keros, our mission is to deliver significant clinical benefit to a wide range of patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta (TGF-ß) family of proteins. With a focus on developing differentiated product candidates that are designed to alter TGF-β signaling, we aim to target the pathways critical for the growth, repair and maintenance of blood cells and a number of tissues, including bone, skeletal muscle, adipose and heart tissue. We believe our product candidates have the potential to unlock the full therapeutic benefits of modulating the TGF-β superfamily and provide disease-modifying benefit to patients. Job Summary: Reporting to the VP, Clinical Development Operations, the Director of Clinical Sciences will serve as the lead Clinical Scientist for the KER-065 program or other assigned study. This person will be responsible for designing and initiating clinical trial(s), supporting clinical data review, interpretation of study results and drive a compound through development. The Director of Clinical Sciences will work closely with the VP, Clinical Development Operations and/or the Medical Director to support various study related activities including drafting clinical development plan, target product profile and represent clinical sciences/development in cross functional teams. In addition, they will contribute to workstreams overseeing data quality, including those involved in CRF data collection, data monitoring and cleaning, and generation of data outputs. This position is based in the company’s Lexington office and requires some domestic and international travel. Responsibilities • Function as the lead Clinical Scientist for the KER-065 program or other assigned program and represent clinical sciences in cross function team meetings. • Lead and support creation of key documents (e.g., Clinical Trial Protocols, Investigator’s Brochures, Clinical Study Reports (CSRs), regulatory documents including INDs/CTAs, NDAs/MAAs and regulatory responses) with high quality and consistency with the Clinical Development Plan. • Collaborate with biostatistics, clinical development, and other applicable team members to participate in relevant and timely data analyses and presentations for safety monitoring committee meetings, regulatory documents, and internal reviews to support timely program decisions regarding study objectives. • Contribute to the study medical/ safety aspects and risk-benefit assessments, collaborating closely with Pharmacovigilance team. • Plan and lead ongoing medical data review in collaboration with data management and other functions. • Work hand-in-hand with the Clinical Operations team for patient centric drug development, ensuring balancing of high medical quality, trial complexity, as well as time and cost considerations. • Own and ensure preparation for clinical sections of key documents, including Investigator's Brochures, IND summary documents, CTAs, responses to questions from regulatory authorities, IRBs and ethics committees, and NDAs. • Contribute to Clinical Study Report (CSR) medical content to ensure high quality expectations on medical standards, provides respective guidance to other members, if needed • Work with the internal team to develop and update key messages on disease states, MOA, target product profile, and scientific platform. • Collaborate with Medical Affairs and other team members on scientific communication of clinical data, including external messaging, publication planning, and congress management. • Author and review abstracts, posters, and manuscripts for publication. • Lead, contribute and drive other initiatives based on the functional goals and corporate objectives. Qualifications • Genuine intere

Apply on employer site ↗